deucravacitinib,apremilast
BMS,amgen
['deucra']
wcd 2023 day 4 afternoon - safety of deucravacitinib in asian patients dr. ronald b. vender reviews the safety of deucravacitinib in asian patients. 
Up-to-date clinical news for dermatology. Publishers of The Chronicle of Skin & Allergy, The Chronicle of Cosmetic Medicine & Surgery, & Skin Spectrum Summit